Age of Onset and Choice of First-line Therapy in Essential Tremor Patients
Objective: The purpose of this study is to examine the effect of age of onset on the selection of initial medication for symptomatic management of…The noradrenergic basis of Parkinson’s tremor
Objective: Study the effect of propranolol on (stress-related increase in) tremor power and on tremor-related activity in the cerebello-thalamo-cortical (CTC) circuit in Parkinson’s (PD) patients.…Therapies, Research Funding and Racial Diversity in Essential Tremor: A Systematic Review of the Literature
Objective: To analyze controlled clinical trials in essential tremor (ET) spanning the last 50 years in order to identify potential shortcomings in the therapeutic clinical…Restless Leg Syndrome After Propranolol Intake: A Single Case
Objective: Present a patient with Restless Leg Syndrome after propranolol administration Background: Restless Leg Syndrome (RLS) is an involuntary need to move the lower extremities or…The mechanism of tremor-modulating properties of propranolol and primidone in essential tremor: A study with transcranial magnetic stimulation and eye blink classical conditioning paradigm
Objective: To explain central mechanisms of propranolol and primidone action and to study pathophysiology of essential tremor (ET). Background: Neurophysiological studies suggest that both motor…Propranolol Induced Visual Hallucinations: A Case Report Charles Bonnets Syndrome in Parkinson Disease
Objective: Charles Bonnets has defined the visual hallucinations (VH) associated with macular degeneration; the syndrome (CBS) is to be remembered by his name. M Background:…Propranolol therapy for tardive dyskinesia: A retrospective examination
Objective: To examine the tolerability and effectiveness of propranolol in treating tardive dyskinesia (TD). Background: TD is a disabling, often irreversible, movement disorder that results…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.